Diltiazem Hydrochloride description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Diltiazem Hydrochloride

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

DILTIAZEM HYDROCHLORIDE DESCRIPTION


Diltiazem Hydrochloride





CLINICAL PHARMACOLOGY



Mechanisms of Action

Angina Due to Coronary Artery Spasm:Diltiazem has been shown to be a potent dilator of coronary arteries both epicardial and subendocardial. Spontaneous and ergonovine-induced coronary artery spasm are inhibited by diltiazem.
Exertional Angina:Diltiazem has been shown to produce increases in exercise tolerance, probably due to its ability to reduce myocardial oxygen demand. This is accomplished via reductions in heart rate and systemic blood pressure at submaximal and maximal exercise workloads.


Hemodynamic and Electrophysiologic Effects





Pharmacokinetics and Metabolism




INDICATIONS & USAGE


DILTIAZEM HYDROCHLORIDE CONTRAINDICATIONS


WARNINGS

1.Cardiac Conduction:Diltiazem prolongs AV node refractory periods without significantly prolonging sinus node recovery time, except in patients with sick sinus syndrome. This effect may rarely result in abnormally slow heart rates (particularly in patients with sick sinus syndrome) or second- or third-degree AV block (six of 1243 patients for 0.48%). Concomitant use of diltiazem with beta-blockers or digitalis may result in additive effects on cardiac conduction. A patient with Prinzmetal's angina developed periods of asystole (2 to 5 seconds) after a single dose of 60 mg of diltiazem (seeADVERSE REACTIONS).
2.Congestive Heart Failure:Although diltiazem has a negative inotropic effect in isolated animal tissue preparations, hemodynamic studies in humans with normal ventricular function have not shown a reduction in cardiac index nor consistent negative effects on contractility (dp/dt). Experience with the use of diltiazem alone or in combination with beta-blockers in patients with impaired ventricular function is very limited. Caution should be exercised when using the drug in such patients.
3.Hypotension:Decreases in blood pressure associated with diltiazem therapy may occasionally result in symptomatic hypotension.
4.Acute Hepatic Injury:In rare instances, significant elevations in enzymes such as alkaline phosphatase, LDH, SGOT, SGPT, and other phenomena consistent with acute hepatic injury have been noted. These reactions have been reversible upon discontinuation of drug therapy. The relationship to diltiazem is uncertain in most cases, but probable in some (seePRECAUTIONS).

PRECAUTIONS

General
Dilitiazem is extensively metabolized by the liver and excreted by the kidneys and in bile. As with any drug given over prolonged periods, laboratory parameters of renal and hepatic function should be monitored at regular intervals. The drug should be used with caution in patients with impaired renal or hepatic function. In subacute and chronic dog and rat studies designed to produce toxicity, high doses of dilitiazem were associated with histological changes in the liver, which were reversible when the drug was discontinued. In dogs, doses of 20 mg/kg were also associated with hepatic changes; however, these changes were reversible with continued dosing. Dermatological events (see ADVERSE REACTIONS) may be transient and may disappear despite continued use of diltiazem. However, skin eruptions progressing to erythema multiforme and/or exfoliative dermatitis have also been infrequently reported. Should a dermatologic reaction persist, the drug should be discontinued.

DRUG INTERACTIONS

WARNINGS).
WARNINGS).










WARNINGS).

















WARNINGS).











CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY


PREGNANCY






NURSING MOTHERS


PEDIATRIC USE


GERIATRIC USE


DILTIAZEM HYDROCHLORIDE ADVERSE REACTIONS




Cardiovascular:Angina, arrhythmia, AV block (first-degree), AV block (second- or third-degreeseeWARNINGS, Cardiac Conduction), bradycardia, bundle branch block, congestive heart failure, ECG abnormality, flushing, hypotension, palpitations, syncope, tachycardia, ventricular extrasystoles.
Nervous System:Abnormal dreams, amnesia, depression, gait abnormality, hallucinations, insomnia, nervousness, paresthesia, personality change, somnolence, tremor.
Gastrointestinal:Anorexia, constipation, diarrhea, dysgeusia, dyspepsia, mild elevations of alkaline phosphatase, SGOT, SGPT, and LDH (seeWARNINGS, Acute Hepatic Injury), thirst, vomiting, weight increase.
Dermatological:Petechiae, photosensitivity, pruritus, urticaria.
Other:Amblyopia, CPK elevation, dry mouth, dyspnea, epistaxis, eye irritation, hyperglycemia, hyperuricemia, impotence, muscle cramps, nasal congestion, nocturia, osteoarticular pain, polyuria, sexual difficulties, tinnitus.

OVERDOSAGE







Bradycardia:Administer atropine (0.6 to 1 mg). If there is no response to vagal blockade, administer isoproterenol cautiously.
High-Degree AV Block:Treat as for bradycardia above. Fixed high-degree AV block should be treated with cardiac pacing.
Cardiac Failure:Administer inotropic agents (isoproterenol, dopamine, or dobutamine) and diuretics.
Hypotension:Vasopressors (e.g., dopamine or norepinephrine).

DOSAGE & ADMINISTRATION

Exertional Angina Pectoris Due to Atherosclerotic Coronary Artery Disease or Angina Pectoris at Rest Due to Coronary Artery Spasm


Concomitant Use With Other Cardiovascular Agents
Sublingual NTGmay be taken as required to abort acute anginal attacks during diltiazem therapy.
Prophylactic Nitrate Therapy:Diltiazem may be safely coadministered with short- and long-acting nitrates, but there have been no controlled studies to evaluate the antianginal effectiveness of this combination.
Beta-blockers.(SeeWARNINGSandPRECAUTIONS.)

HOW SUPPLIED






STORAGE AND HANDLING



PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Diltiazem Hydrochloride


Diltiazem Hydrochloride

Diltiazem Hydrochloride

DILTIAZEM HYDROCHLORIDE TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-557(NDC:0093-0318)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
DILTIAZEM HYDROCHLORIDE DILTIAZEM 30 mg

Inactive Ingredients

Ingredient Name Strength
HYPROMELLOSES
lactose monohydrate
MAGNESIUM STEARATE
polyethylene glycol
polysorbate 80
titanium dioxide
FD&C YELLOW NO. 6
ALUMINUM OXIDE

Product Characteristics

Color Size Imprint Code Shape
orange 8 mm 93;318 ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-557-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA074185 2012-08-31


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.